Followers | 43 |
Posts | 4255 |
Boards Moderated | 0 |
Alias Born | 07/14/2010 |
Wednesday, August 23, 2017 12:52:42 PM
CAVE CREEK, AZ--(Marketwired - Aug 23, 2017) - Endexx Corporation (OTC PINK: EDXC), a provider of innovative phyto-nutrient-based food and nutritional products, has engaged Eventus Consulting, P.C. to assist with the completion of preparing accounting records for the current audit underway for fiscal years 2015 and 2016. Eventus will coordinate with Endexx's auditor Turner & Stone for the audit's completion.
As part of the engagement, Eventus will facilitate final preparations for the SEC registration and filing and help provide the infrastructure for all fiscal reporting requirements going forward.
Eventus Consulting, P.C. is a registered CPA firm in Scottsdale, Arizona and is affiliated with Eventus Advisory Group, LLC that provides capitalization planning, consultation on initial public filings, as well as finance department creation, organization, implementation and maintenance to small and medium sized companies. Eventus Advisory Group, LLC offers a wide variety of services that enable its clients to grow and to achieve their financial objectives.
Todd Davis, CEO of Endexx, commented, "Having a strong financial team is especially critical during this time as we become up-to-date in our reporting and pursue our plan to up-list. Our engagement with Eventus will spearhead our initiative in finalizing our financial reporting process and their expertise will be valuable as we continue to grow our company and sales."
Recent EDXC News
- Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • InvestorsHub NewsWire • 03/27/2024 07:01:28 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM